Michael S. Ostrach
Overview
Michael S. Ostrach received an average of $1M in total compensation, including $359K in salary, at Dynavax Technologies from 2007 to 2018. Michael Ostrach also received $741K at Threshold Pharmaceuticals in 2006.
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2009
- 2008
Dynavax TechnologiesSenior Vice President, Chief Financial Officer, Chief Business Officer
Dynavax TechnologiesSenior Vice President, Chief Financial Officer, Chief Business Officer
Dynavax TechnologiesSenior Vice President, Chief Financial Officer, Chief Business Officer
Dynavax TechnologiesSenior Vice President, Chief Financial Officer, Chief Business Officer
Dynavax TechnologiesSenior Vice President, Chief Financial Officer, Chief Business Officer
Dynavax TechnologiesSenior Vice President, Chief Financial Officer and Chief Business Officer
Dynavax TechnologiesVice President, Chief Financial Officer, Chief Business Officer and General Counsel
Dynavax TechnologiesVice President, Chief Business and Principal Financial Officer and General Counsel
Dynavax TechnologiesVice President, Chief Business Officer and General Counsel
Dynavax TechnologiesVice President, Chief Business Officer and General Counsel
Source: SEC filings on April 22, 2019, April 20, 2018, April 21, 2017, April 22, 2016, April 21, 2015, April 28, 2014, November 30, 2010, and April 6, 2007.
Related executives
We found 29 more executives who work or worked at Dynavax Technologies and Threshold Pharmaceuticals.
Eric Poma
Threshold Pharmaceuticals
Chief Executive Officer
Roger Waltzman
Threshold Pharmaceuticals
Chief Medical Officer
Jason Kim
Threshold Pharmaceuticals
Chief Operating Officer
Eddie Gray
Dynavax Technologies
Chief Executive Officer
Robert Coffman
Dynavax Technologies
Chief Scientific Officer
Robert Janssen
Dynavax Technologies
Chief Medical Officer
David Novack
Dynavax Technologies
Senior Vice President, Operations and Quality
Adam Cutler
Threshold Pharmaceuticals